Advertisement

Late Effects of Treatment and Palliative Care

  • Eric Chang
  • Robert Goldsby
  • Sabine Mueller
  • Anu BanerjeeEmail author
Chapter
Part of the Pediatric Oncology book series (PEDIATRICO)

Abstract

Identifying late effects of treatment and integrating palliative care when appropriate are increasingly recognized as important elements of childhood tumor management. Patients with CNS tumors are at a high risk for mortality, and survivors have high morbidity rates related to the late effects of treatment. While intensified therapy has improved average 5-year survival in patients with pediatric brain tumors to 73 % (Ostrom et al. 2014) from less than 60 % in 1975–1979 (Linabery and Ross 2008), it has also increased the long-term consequences. Survivors may develop a spectrum of late effects ranging from subtle memory loss and cosmetic anomalies to severe neurological disabilities and recurrent neoplasms. While seemingly quite different, both palliative and late-effects care focus on improving quality of life for patients and need to be integrated into the overall care plan.

Keywords

Palliative Care Growth Hormone Deficiency Cranial Radiation Childhood Cancer Survivor Pediatric Brain Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Anderson DM, Rennie KM, Ziegler RS, Neglia JP, Robison LR, Gurney JG (2001) Medical and neurocognitive late effects among survivors of childhood central nervous system tumors. Cancer 92:2709–2719PubMedCrossRefGoogle Scholar
  2. Anderson FS, Kunin-Batson AS (2009) Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatr Blood Cancer 52:159–164PubMedCrossRefGoogle Scholar
  3. Anderson NE (2003) Late complications in childhood central nervous system tumour survivors. Curr Opin Neurol 16:677–683PubMedCrossRefGoogle Scholar
  4. Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ (2009a) Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study. J Natl Cancer Inst 101:946–958PubMedPubMedCentralCrossRefGoogle Scholar
  5. Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC (2009b) Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 27:2328–2338PubMedPubMedCentralCrossRefGoogle Scholar
  6. Armstrong GT (2010) Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc 14:298–303CrossRefGoogle Scholar
  7. Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson MM, Sklar CA, Robison LL, Oeffinger KC (2014) Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 32:1218–1227PubMedPubMedCentralCrossRefGoogle Scholar
  8. Askins MA, Moore BD (2008) Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol 23:1160–1171PubMedPubMedCentralCrossRefGoogle Scholar
  9. Ater JL, Moore BD III, Francis DJ, Castillo R, Slopis J, Copeland DR (1996) Correlation of medical and neurosurgical events with neuropsychological status in children at diagnosis of astrocytoma: utilization of a neurological severity score. J Child Neurol 11:462–469PubMedCrossRefGoogle Scholar
  10. Barr RD, Simpson T, Whitton A, Rush B, Furlong W, Feeny DH (1999) Health-related quality of life in survivors of tumours of the central nervous system in childhood–a preference-based approach to measurement in a cross-sectional study. Eur J Cancer 35:248–255PubMedCrossRefGoogle Scholar
  11. Behin A, Delattre JY (2002) Neurological sequelae of radiation therapy on the nervous system. In: Schiff D, Wen PY (eds) Cancer neurology in clinical practice. Humana, Totowa, pp 173–191CrossRefGoogle Scholar
  12. Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, Robison LL, Packer RJ, Oeffinger KC (2006) Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24:5277–5282PubMedCrossRefGoogle Scholar
  13. Brinkman TM, Zhu L, Zeltzer LK, Recklitis CJ, Kimberg C, Zhang N, Muriel AC, Stovall M, Srivastava DK, Robison LL, Krull KR (2013) Longitudinal patterns of psychological distress in adult survivors of childhood cancer. Br J Cancer 109:1373–1381PubMedPubMedCentralCrossRefGoogle Scholar
  14. Brinkman TM, Zhang N, Recklitis CJ, Kimberg C, Zeltzer LK, Muriel AC, Stovall M, Srivastava DK, Sklar CA, Robison LL, Krull KR (2014) Suicide ideation and associated mortality in adult survivors of childhood cancer. Cancer 120:271–277PubMedCrossRefGoogle Scholar
  15. Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, Robison LL, Sklar CA (2004) Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 89:4422–4427PubMedCrossRefGoogle Scholar
  16. Butler RW, Hill JM, Steinherz PG, Meyers PA, Finlay JL (1994) Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. J Clin Oncol 12:2621–2629PubMedGoogle Scholar
  17. Byrne J, Lewis S, Halamek L, Connelly RR, Mulvihill JJ (1989) Childhood cancer survivors’ knowledge of their diagnosis and treatment. Ann Intern Med 110:400–403PubMedCrossRefGoogle Scholar
  18. Carpentieri SC, Meyer EA, Delaney BL, Victoria ML, Gannon BK, Doyle JM, Kieran MW (2003) Psychosocial and behavioral functioning among pediatric brain tumor survivors. J Neurooncol 63:279–287PubMedCrossRefGoogle Scholar
  19. Carroll PV, Christ ER, Sonksen PH (2000) Growth hormone replacement in adults with growth hormone deficiency: assessment of current knowledge. Trends Endocrinol Metab 11:231–238PubMedCrossRefGoogle Scholar
  20. Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, Shaw EG, Parsons SK (2012) Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study. Pediatr Blood Cancer 59:540–547PubMedPubMedCentralCrossRefGoogle Scholar
  21. Clanton NR, Klosky JL, Li C, Jain N, Srivastava DK, Mulrooney D, Zeltzer L, Stovall M, Robison LL, Krull KR (2011) Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 117:2559–2568PubMedPubMedCentralCrossRefGoogle Scholar
  22. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P (1993) Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328:87–94PubMedCrossRefGoogle Scholar
  23. Contro NA, Larson J, Scofield S, Sourkes B, Cohen HJ (2004) Hospital staff and family perspectives regarding quality of pediatric palliative care. Pediatrics 114:1248–1252PubMedCrossRefGoogle Scholar
  24. Darzy KH, Shalet SM (2009) Hypopituitarism following radiotherapy revisited. Endocr Dev 15:1–24PubMedGoogle Scholar
  25. Duffner PK (2010) Risk factors for cognitive decline in children treated for brain tumors. Eur J Paediatr Neurol 14:106–115PubMedCrossRefGoogle Scholar
  26. Ellenberg L, McComb JG, Siegel SE, Stowe S (1987) Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21:638–644PubMedCrossRefGoogle Scholar
  27. Ellenberg L, Liu Q, Gioia G, Yasui Y, Packer RJ, Mertens A, Donaldson SS, Stovall M, Kadan-Lottick N, Armstrong G, Robison LL, Zeltzer LK (2009) Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the Childhood Cancer Survivor Study. Neuropsychology 23:705–717PubMedPubMedCentralCrossRefGoogle Scholar
  28. Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA (2006) Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91:3494–3498PubMedCrossRefGoogle Scholar
  29. Flint H, Weidner N (2012) Crossing the chasm: understanding modern practice and application of pediatric palliative care. Int Anesthesiol Clin 50:96–108PubMedCrossRefGoogle Scholar
  30. Foreman NK, Faestel PM, Pearson J, Disabato J, Poole M, Wilkening G, Arenson EB, Greffe B, Thorne R (1999) Health status in 52 long-term survivors of pediatric brain tumors. J Neurooncol 41:47–53PubMedCrossRefGoogle Scholar
  31. Foster TL, Lafond DA, Reggio C, Hinds PS (2010) Pediatric palliative care in childhood cancer nursing: from diagnosis to cure or end of life. Semin Oncol Nurs 26:205–221PubMedCrossRefGoogle Scholar
  32. Fowler K, Poehling K, Billheimer D, Hamilton R, Wu H, Mulder J, Frangoul H (2006) Hospice referral practices for children with cancer: a survey of pediatric oncologists. J Clin Oncol 24:1099–1104PubMedCrossRefGoogle Scholar
  33. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP (2010) Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 102:1083–1095PubMedPubMedCentralCrossRefGoogle Scholar
  34. Gastelum E, Sear K, Hills N, Roddy E, Randazzo D, Chettout N, Hess C, Cotter J, Haas-Kogan DA, Fullerton H, Mueller S (2015) Rates and characteristics of radiographically detected intracerebral cavernous malformations after cranial radiation therapy in pediatric cancer patients. J Child Neurol 30(7):842–849, published onlinePubMedCrossRefGoogle Scholar
  35. Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, Jaspers MW, Koning CC, Olden-burger F, Langeveld NE, Hart AA, Bakker PJ, Caron HN, van Leeuwen FE (2007) Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297:2705–2715PubMedCrossRefGoogle Scholar
  36. Gleeson HK, Shalet SM (2004) The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer 11:589–602PubMedCrossRefGoogle Scholar
  37. Goldman A (1998) ABC of palliative care. Special problems of children. BMJ 316:49–52PubMedPubMedCentralCrossRefGoogle Scholar
  38. Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, Dellatolas G, Raquin MA, Jambaque I, Kalifa C (1999) Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 45:137–145PubMedCrossRefGoogle Scholar
  39. Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, Stovall M, Yasui Y, Nicholson HS, Wolden S, McNeil DE, Mertens AC, Robison LL (2003a) Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97:663–673PubMedCrossRefGoogle Scholar
  40. Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Neglia JP, Mertens AC, Packer RJ, Robison LL, Sklar CA (2003b) Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J Clin Endocrinol Metabol 88:4731–4739CrossRefGoogle Scholar
  41. Hain R, Weinstein S, Oleske J, Orloff S, Cohn S (2004) Holistic management of symptoms. In: Carter BS, Levetown M (eds) Palliative care for infants, children and adolescents: a practical handbook. Johns Hopkins University Press, Baltimore, pp 163–195Google Scholar
  42. Hays DM, Landsverk J, Sallan SE, Hewett KD, Patenaude AF, Schoonover D, Zilber SL, Ruccione K, Siegel SE (1992) Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life. J Clin Oncol 10:1397–1406PubMedGoogle Scholar
  43. Hilden JM, Emanuel EJ, Fairclough DL, Link MP, Foley KM, Clarridge BC, Schnipper LE, Mayer RJ (2001) Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol 19:205–212PubMedGoogle Scholar
  44. Horstmann E, McCabe MS, Grochow L, Yamamoto S, Rubinstein L, Budd T, Shoemaker D, Emanuel EJ, Grady C (2005) Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engla J Med 352:895–904CrossRefGoogle Scholar
  45. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2014) SEER cancer statistics review, 1975-2011. National Cancer Institute, BethesdaGoogle Scholar
  46. Huang TT, Chen Y, Dietz AC, Yasui Y, Donaldson SS, Stokes DC, Stovall M, Leisenring WM, Sklar CA, Diller LR, Mertens AC, Armstrong GT, Green DM, Robison LL, Ness KK (2014) Pulmonary outcomes in survivors of childhood central nervous system malignancies: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 61:319–325PubMedCrossRefGoogle Scholar
  47. Hudson MM, Tyc VL, Srivastava DK, Gattuso J, Quargnenti A, Crom DB, Hinds P (2002) Multi-component behavioral intervention to promote health protective behaviors in childhood cancer survivors: the protect study. Med Pediatr Oncol 39:2–11; discussion 2PubMedCrossRefGoogle Scholar
  48. Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, Yeazel M, Recklitis CJ, Marina N, Robison LR, Oeffinger KC (2003) Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA 290:1583–1592PubMedCrossRefGoogle Scholar
  49. Ilveskoski I, Pihko H, Sankila R, Lanning M, Perkkio M, Aarimaa T, Makipernaa A, Saarinen UM (1997) Improving outcome of malignant brain tumours in very young children: a population-based study in Finland during 1975–93. Acta Paediatr 86:724–729PubMedCrossRefGoogle Scholar
  50. Jakacki RI, Goldwein JW, Larsen RL, Barber G, Silber JH (1993) Cardiac dysfunction following spinal irradiation during childhood. J Clin Oncol 11:1033–1038PubMedGoogle Scholar
  51. Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, Hudson M, Greenberg M, Mertens AC (2002) Childhood cancer survivors’ knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. JAMA 287:1832–1839PubMedCrossRefGoogle Scholar
  52. Kao GD, Goldwein JW, Schultz DJ, Radcliffe J, Sutton L, Lange B (1994) The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors. Cancer 74:965–971PubMedCrossRefGoogle Scholar
  53. Kirchhoff AC, Krull KR, Ness KK, Park ER, Oeffinger KC, Hudson MM, Stovall M, Robison LL, Wickizer T, Leisenring W (2011) Occupational outcomes of adult childhood cancer survivors: a report from the childhood cancer survivor study. Cancer 117:3033–3044PubMedPubMedCentralCrossRefGoogle Scholar
  54. Klick JC, Hauer J (2010) Pediatric palliative care. Curr Probl Pediatr Adolesc Health Care 40:120–151PubMedCrossRefGoogle Scholar
  55. Klopfenstein KJ, Hutchison C, Clark C, Young D, Ruymann FB (2001) Variables influencing end-of-life care in children and adolescents with cancer. J Pediatr Hematol Oncol 23:481–486PubMedCrossRefGoogle Scholar
  56. Kolarik RC, Walker G, Arnold RM (2006) Pediatric resident education in palliative care: a needs assessment. Pediatrics 117:1949–1954PubMedCrossRefGoogle Scholar
  57. Korones DN (2007) Pediatric palliative care. Pediatr Rev 28:e46–e56PubMedCrossRefGoogle Scholar
  58. Kreicbergs U, Valdimarsdottir U, Onelov E, Henter JI, Steineck G (2004) Talking about death with children who have severe malignant disease. N Engl J Med 351:1175–1186PubMedCrossRefGoogle Scholar
  59. Kurzrock R, Benjamin RS (2005) Risks and benefits of phase 1 oncology trials, revisited. N Engl J Med 352:930–932PubMedCrossRefGoogle Scholar
  60. Langeveld NE, Grootenhuis MA, Voute PA, de Haan RJ, van den Bos C (2003) No excess fatigue in young adult survivors of childhood cancer. Eur J Cancer 39:204–214PubMedCrossRefGoogle Scholar
  61. Lannen PK, Wolfe J, Prigerson HG, Onelov E, Kreicbergs UC (2008) Unresolved grief in a national sample of bereaved parents: impaired mental and physical health 4 to 9 years later. J Clin Oncol 26:5870–5876PubMedPubMedCentralCrossRefGoogle Scholar
  62. Lannering B, Marky I, Lundberg A, Olsson E (1990) Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. Med Pediatr Oncol 18:304–310PubMedCrossRefGoogle Scholar
  63. Levy AS (2005) Brain tumors in children: evaluation and management. Curr Probl Pediatr Adolesc Health Care 35:230–245PubMedCrossRefGoogle Scholar
  64. Linabery AM, Ross JA (2008) Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer 113:2575–2596PubMedPubMedCentralCrossRefGoogle Scholar
  65. Livesey EA, Hindmarsh PC, Brook CG, Whitton AC, Bloom HJ, Tobias JS, Godlee JN, Britton J (1990) Endocrine disorders following treatment of childhood brain tumours. Br J Cancer 61:622–625PubMedPubMedCentralCrossRefGoogle Scholar
  66. Lu Q, Krull KR, Leisenring W, Owen JE, Kawashima T, Tsao JC, Zebrack B, Mertens A, Armstrong GT, Stovall M, Robison LL, Zeltzer LK (2011) Pain in long-term adult survivors of childhood cancers and their siblings: a report from the Childhood Cancer Survivor Study. Pain 152:2616–2624PubMedPubMedCentralCrossRefGoogle Scholar
  67. Lupo JM, Chuang CF, Chang SM, Barani IJ, Jimenez B, Hess CP, Nelson SJ (2012) 7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys 82:e493–e500PubMedCrossRefGoogle Scholar
  68. Mabbott DJ, Spiegler BJ, Greenberg ML, Rutka JT, Hyder DJ, Bouffet E (2005) Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J Clin Oncol 23:2256–2263PubMedCrossRefGoogle Scholar
  69. Meeske KA, Patel SK, Palmer SN, Nelson MB, Parow AM (2007) Factors associated with health-related quality of life in pediatric cancer survivors. Pediatr Blood Cancer 49:298–305PubMedCrossRefGoogle Scholar
  70. Merchant TE, Gould CJ, Xiong X, Robbins N, Zhu J, Pritchard DL, Khan R, Heideman RL, Krasin MJ, Kun LE (2004) Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors. Int J Radiat Oncol Biol Phys 58:1194–1207PubMedCrossRefGoogle Scholar
  71. Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, Robison LL, Yasui Y (2008) Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 100:1368–1379PubMedPubMedCentralCrossRefGoogle Scholar
  72. Mitby PA, Robison LL, Whitton JA, Zevon MA, Gibbs IC, Tersak JM, Meadows AT, Stovall M, Zeltzer LK, Mertens AC, Childhood Cancer Survivor Study Steering Committee (2003) Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 97:1115–1126PubMedCrossRefGoogle Scholar
  73. Moe PJ, Holen A (2000) High-dose methotrexate in childhood all. Pediatr Hematol Oncol 17:615–622PubMedCrossRefGoogle Scholar
  74. Moleski M (2000) Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol 15:603–630PubMedCrossRefGoogle Scholar
  75. Moshang T Jr, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A (1996) Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 128:S4–S7PubMedCrossRefGoogle Scholar
  76. Mostow EN, Byrne J, Connelly RR, Mulvihill JJ (1991) Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol 9:592–599PubMedGoogle Scholar
  77. Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Scantlebury N, Law N, Spiegler BJ, Malkin D, Janzen L, Mabbott D (2014) Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol 32:1760–1768PubMedCrossRefGoogle Scholar
  78. Mueller S, Fullerton HJ, Stratton K, Leisenring W, Weathers RE, Stovall M, Armstrong GT, Goldsby RE, Packer RJ, Sklar CA, Bowers DC, Robison LL, Krull KR (2013) Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys 86:649–655PubMedPubMedCentralCrossRefGoogle Scholar
  79. Muirhead SE, Hsu E, Grimard L, Keene D (2002) Endocrine complications of pediatric brain tumors: case series and literature review. Pediatr Neurol 27:165–170PubMedCrossRefGoogle Scholar
  80. Mulhern RK, Hancock J, Fairclough D, Kun L (1992) Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med Pediatr Oncol 20:181–191PubMedCrossRefGoogle Scholar
  81. Mulhern RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun LE (1998) Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J Clin Oncol 16:1723–1728PubMedGoogle Scholar
  82. Mulrooney DA, Ness KK, Neglia JP, Whitton JA, Green DM, Zeltzer LK, Robison LL, Mertens AC (2008) Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep 31:271–281PubMedPubMedCentralGoogle Scholar
  83. Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, Donaldson SS, Green DM, Sklar CA, Robison LL, Leisenring WM (2009) Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. Br Med J 339:b4606CrossRefGoogle Scholar
  84. Murphy SL, Xu J, Kochanek KD (2013) Deaths: final data for 2010. Natl Vital Stat Rep 61:1–118PubMedGoogle Scholar
  85. Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L (2008) Endocrine late effects of childhood cancer therapy: a report from the Children’s Oncology Group. Horm Res 69:65–74PubMedCrossRefGoogle Scholar
  86. Nathan PC, Patel SK, Dilley K, Goldsby R, Harvey J, Jacobsen C, Kadan-Lottick N, McKinley K, Millham AK, Moore I, Okcu MF, Woodman CL, Brouwers P, Armstrong FD (2007) Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children’s Oncology Group. Arch Pediatr Adolesc Med 161:798–806PubMedCrossRefGoogle Scholar
  87. Nathan PC, Ness KK, Mahoney MC, Li Z, Hudson MM, Ford JS, Landier W, Stovall M, Armstrong GT, Henderson TO, Robison LL, Oeffinger KC (2010) Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Ann Intern Med 153:442–451PubMedPubMedCentralCrossRefGoogle Scholar
  88. Oberfield SE, Allen JC, Pollack J, New MI, Levine LS (1986) Long-term endocrine sequelae after treatment of medullo-blastoma: prospective study of growth and thyroid function. J Pediatr 108:219–223PubMedCrossRefGoogle Scholar
  89. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582PubMedCrossRefGoogle Scholar
  90. Oeffinger KC, Nathan PC, Kremer LC (2008) Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Pediatr Clin North Am 55:251–273, xiiiPubMedCrossRefGoogle Scholar
  91. Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR (1991) Thyroid function after treatment of brain tumors in children. J Pediatr 119:733–737PubMedCrossRefGoogle Scholar
  92. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan J (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol 16:iv1–v63PubMedPubMedCentralCrossRefGoogle Scholar
  93. Packer RJ, Mehta M (2002) Neurocognitive sequelae of cancer treatment. Neurology 59:8–10PubMedCrossRefGoogle Scholar
  94. Packer RJ, Sutton LN, Atkins TE, Radcliffe J, Bunin GR, D’Angio G, Siegel KR, Schut L (1989) A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results. J Neurosurg 70:707–713PubMedCrossRefGoogle Scholar
  95. Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, Yasui Y, Mertens AC, Sklar CA, Nicholson HS, Zeltzer LK, Neglia JP, Robison LL (2003) Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 21:3255–3261PubMedCrossRefGoogle Scholar
  96. Padovani L, André N, Constine LS, Muracciole X (2012) Neurocognitive function after radiotherapy for paediatric brain tumours. Nat Rev Neurol 8:578–588PubMedCrossRefGoogle Scholar
  97. Pang JW, Friedman DL, Whitton JA, Stovall M, Mertens AC, Robison LL, Weiss NS (2008) Employment status among adult survivors in the Childhood Cancer Survivor Study. Pediatr Blood Cancer 50:104–110PubMedCrossRefGoogle Scholar
  98. Patterson BC, Chen Y, Sklar CA, Neglia J, Yasui Y, Mertens A, Armstrong GT, Meadows A, Stovall M, Robison LL, Meacham LR (2014) Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 99:2030–2037PubMedPubMedCentralCrossRefGoogle Scholar
  99. Pizzo PA, Poplack DG, Bleyer WA (1979) Neurotoxicities of current leukemia therapy. Am Jo Pediatr Hematol Oncol 1:127–140Google Scholar
  100. Pollak KI, Arnold RM, Jeffreys AS, Alexander SC, Olsen MK, Abernethy AP, Sugg Skinner C, Rodriguez KL, Tulsky JA (2007) Oncologist communication about emotion during visits with patients with advanced cancer. J Clin Oncol 25:5748–5752PubMedCrossRefGoogle Scholar
  101. Poltorak DY, Glazer JP (2006) The development of children’s understanding of death: cognitive and psychodynamic considerations. Child Adolesc Psychiatr Clin N Am 15:567–573PubMedCrossRefGoogle Scholar
  102. Radcliffe J, Packer RJ, Atkins TE, Bunin GR, Schut L, Goldwein JW, Sutton LN (1992) Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy. Ann Neurol 32:551–554PubMedCrossRefGoogle Scholar
  103. Recklitis CJ, Diller LR, Li X, Najita J, Robison LL, Zeltzer L (2010) Suicide ideation in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 28:655–661PubMedCrossRefGoogle Scholar
  104. Reddick WE, Russell JM, Glass JO, Xiong X, Mulhern RK, Langston JW, Merchant TE, Kun LE, Gajjar A (2000) Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging 18:787–793PubMedCrossRefGoogle Scholar
  105. Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM (2001) Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children’s Cancer Group study. J Clin Oncol 19:3470–3476PubMedGoogle Scholar
  106. Ross L, Johansen C, Dalton SO, Mellemkjaer L, Thomassen LH, Mortensen PB, Olsen JH (2003) Psychiatric hospitalizations among survivors of cancer in childhood or adolescence. N Engl J Med 349:650–657PubMedCrossRefGoogle Scholar
  107. Rueckriegel SM, Driever PH, Blankenburg F, Lüdemann L, Henze G, Bruhn H (2010) Differences in supratentorial damage of white matter in pediatric survivors of posterior fossa tumors with and without adjuvant treatment as detected by magnetic resonance diffusion tensor imaging. Int J Radiat Oncol Biol Phys 76:859–866PubMedCrossRefGoogle Scholar
  108. Rutter MM, Rose SR (2007) Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr 19:480–487PubMedCrossRefGoogle Scholar
  109. Saha A, Salley CG, Saigal P, Rolnitzky L, Goldberg J, Scott S, Olshefski R, Hukin J, Sands SA, Finlay J, Gardner SL (2014) Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols. Pediatr Blood Cancer 61:1644–1652PubMedPubMedCentralCrossRefGoogle Scholar
  110. Sahler OJ, Frager G, Levetown M, Cohn FG, Lipson MA (2000) Medical education about end-of-life care in the pediatric setting: principles, challenges, and opportunities. Pediatrics 105:575–584PubMedCrossRefGoogle Scholar
  111. Sands SA, Oberg JA, Gardner SL, Whiteley JA, Glade-Bender JL, Finlay JL (2010) Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors. Pediatr Blood Cancer 54:429–436PubMedCrossRefGoogle Scholar
  112. Schiff D, Wen P (2006) Central nervous system toxicity from cancer therapies. Hematol Oncol Clin North Am 20:1377–1398PubMedCrossRefGoogle Scholar
  113. Sirkia K, Saarinen UM, Ahlgren B, Hovi L (1997) Terminal care of the child with cancer at home. Acta Paediatr 86:1125–1130PubMedCrossRefGoogle Scholar
  114. Sklar CA, Constine LS (1995) Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31:1113–1121PubMedCrossRefGoogle Scholar
  115. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL (2002) Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87:3136–3141PubMedCrossRefGoogle Scholar
  116. Smithson EF, Phillips R, Harvey DW, Morrall MC (2013) The use of stimulant medication to improve neurocognitive and learning outcomes in children diagnosed with brain tumours: a systematic review. Eur J Cancer 49:3029–3040PubMedCrossRefGoogle Scholar
  117. Sønderkaer S, Schmiegelow M, Carstensen H, Nielsen LB, Müller J, Schmiegelow K (2003) Long-term neurological outcome of childhood brain tumors treated by surgery only. J Clin Oncol 21:1347–1351PubMedCrossRefGoogle Scholar
  118. Spinetta JJ, Jankovic M, Eden T, Green D, Martins AG, Wandzura C, Wilbur J, Masera G (1999) Guidelines for assistance to siblings of children with cancer: report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Med Pediatr Oncol 33:395–398PubMedCrossRefGoogle Scholar
  119. Steinlin M, Imfeld S, Zulauf P, Boltshauser E, Lovblad KO, Ridolfi Luthy A, Perrig W, Kaufmann F (2003) Neuropsychological long-term sequelae after posterior fossa tumour resection during childhood. Brain 126:1998–2008PubMedCrossRefGoogle Scholar
  120. Stuber ML, Meeske KA, Krull KR, Leisenring W, Stratton K, Kazak AE, Huber M, Zebrack B, Uijtdehaage SH, Mertens AC, Robison LL, Zeltzer LK (2010) Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer. Pediatrics 125:e1124–e1134PubMedPubMedCentralCrossRefGoogle Scholar
  121. Syndikus I, Tait D, Ashley S, Jannoun L (1994) Long-term follow-up of young children with brain tumors after irradiation. Int J Radiat Oncol Biol Phys 30:781–787PubMedCrossRefGoogle Scholar
  122. Thomson AB, Critchley HO, Kelnar CJ, Wallace WH (2002) Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation. Best Pract Res Clin Endocrinol Metab 16:311–334PubMedCrossRefGoogle Scholar
  123. Tofilon PJ, Fike JR (2000) The radioresponse of the central nervous system: a dynamic process. Radiat Res 153:357–370PubMedCrossRefGoogle Scholar
  124. Turner CD, Rey-Casserly C, Liptak CC, Chordas C (2009) Late effects of therapy for pediatric brain tumor survivors. J Child Neurol 24:1455–1463PubMedCrossRefGoogle Scholar
  125. Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL (2007) Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 68:932–938PubMedCrossRefGoogle Scholar
  126. von Gunten CF, Ferris FD, Emanuel LL (2000) The patient-physician relationship. Ensuring competency in end-of-life care: communication and relational skills. JAMA 284:3051–3057CrossRefGoogle Scholar
  127. Waber DP, Tarbell NJ, Fairclough D, Atmore K, Castro R, Isquith P, Lussier F, Romero I, Carpenter PJ, Schiller M et al (1995) Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 13:2490–2496PubMedGoogle Scholar
  128. Waldman E, Wolfe J (2013) Palliative care for children with cancer. Nat Rev Clin Oncol 10:100–107PubMedCrossRefGoogle Scholar
  129. Wheeler I (2001) Parental bereavement: the crisis of meaning. Death Stud 25:51–66PubMedCrossRefGoogle Scholar
  130. Wiener L, Zadeh S, Battles H, Baird K, Ballard E, Osherow J, Pao M (2012) Allowing adolescents and young adults to plan their end-of-life care. Pediatrics 130:897–905PubMedPubMedCentralCrossRefGoogle Scholar
  131. Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, Emanuel EJ, Weeks JC (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342:326–333PubMedCrossRefGoogle Scholar
  132. Wolfe J, Hammel JF, Edwards KE, Duncan J, Comeau M, Breyer J, Aldridge SA, Grier HE, Berde C, Dussel V, Weeks JC (2008) Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol 26:1717–1723PubMedCrossRefGoogle Scholar
  133. Wusthoff CJ, Shellhaas RA, Licht DJ (2007) Management of common neurologic symptoms in pediatric palliative care: seizures, agitation, and spasticity. Pediatr Clin North Am 54:709–733, xiPubMedCrossRefGoogle Scholar
  134. Zebrack BJ, Chesler MA (2002) Quality of life in childhood cancer survivors. Psychooncology 11:132–141PubMedCrossRefGoogle Scholar
  135. Zeltzer LK, Lu Q, Leisenring W, Tsao JC, Recklitis C, Armstrong G, Mertens AC, Robison LL, Ness KK (2008) Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 17:435–446PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing 2017

Authors and Affiliations

  • Eric Chang
    • 1
  • Robert Goldsby
    • 2
  • Sabine Mueller
    • 3
  • Anu Banerjee
    • 2
    Email author
  1. 1.Department of Radiation OncologyUniversity of California Los AngelesLos AngelesUSA
  2. 2.Division of Hematology/Oncology, Departments of PediatricsUniversity of California San Francisco & UCSF Benioff Children’s HospitalSan FranciscoUSA
  3. 3.Departments of Neurology, Neurosurgery and PediatricsUniversity of California San Francisco & UCSF Benioff Children’s HospitalSan FranciscoUSA

Personalised recommendations